The global Antibody Development and Production Service market size is predicted to grow from US$ 2340 million in 2025 to US$ 3668 million in 2031; it is expected to grow at a CAGR of 7.8% from 2025 to 2031.

Antibody development and production service is a broader service that covers the development, optimization, and production of monoclonal and polyclonal antibodies. This service typically includes antigen design and preparation, antibody screening and optimization (such as affinity maturation, Fc modification, etc.), antibody expression and purification, as well as antibody functional validation (such as ELISA, Western blot, flow cytometry, etc.). Suitable for antibody needs in different fields such as scientific research, diagnosis, and treatment.

Segmentation by Type:

• Monoclonal Antibodies
• Polyclonal Antibodies

Segmentation by Application:

• Medical
• Pharmaceutical
• Scientific Research

Market by Region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Companies Coverage:

• ThermoFisher
• Abcam
• BICO
• Rockland
• ProSci
• Biocompare
• Bio-Rad
• Evitria AG
• Capra Science
• Innovagen
• Life Science Group
• Randox
• Davids Biotechnologie
• Abgent
• InVivo BioTech Services
• BioGenes
• Helmholtz Zentrum München
• Kaneka Eurogentec
• Beijing Abace Biology
• Beijing Sino Biological
• Nanjing GenScript Biotechnology
• Shanghai Sangon Biotech
• Nanjing Zoonbio Biotechnology
• Suzhou Synbio Technologies

Key Questions Addressed in this Report: